Biomarker May Predict Response to Cancer Therapy

SUNDAY, April 13 (HealthDay News) -- A biomarker that may help doctors monitor the effectiveness of common treatments for kidney cancer and non-small cell lung cancer has been identified by researchers in the Netherlands.

Related Subjects

Netherlands

San Diego

Amsterdam

American Association for Cancer Research

Avastin

Sutent

VU University Medical Center

National Academies Press

Europe

Western Europe

Benelux

Medicine

Health and Fitness

Cancer

Lung Cancer

Powered by Inform

Related Articles

Mouth Swab May One Day Diagnose Lung Cancer Forbes 4/16/2008 9:17:28 PM

$3 Billion Asbestos Deal Reached by W.R.Grace Company to Pay Asbestos Victims FindLaw 4/16/2008 4:06:23 PM

Calling for a Cure FindLaw 4/16/2008 3:16:16 PM

Pacific Heart, Lung & Blood Institute Position on Ban Asbestos Legislation FindLaw 4/16/2008 3:15:41 PM

Market Report -- In Play (OSIP) MSN Money 4/16/2008 2:23:32 PM

Optimistic about lungs The Star, Malaysia 4/16/2008 1:59:40 PM

Measuring Medicine: How New Technologies Could Help Doctors Predict Patient Outcomes NewsBlaze 4/16/2008 12:23:48 PM

Aging: How Growing Older Affects Cancer Risk and Outcomes NewsBlaze 4/16/2008 11:50:11 AM

VioQuest Pharmaceuticals' Novel Akt Inhibitor VQD-002 is Synergistic with Various Cancer Therapies in Preclinical Studies Drugs.com 4/16/2008 10:42:48 AM

U.S. Patent and Trademark Office Grants Biomoda Notice of... MSN Money 4/16/2008 9:19:16 AM

Related Blogs

Law Firm of the Day: Belluck & Fox Abovethelaw.com 4/16/2008 11:48:16 AM

Related Video

New Cancer Research Revealed NBC San Diego Video 4/15/2008 12:13:29 AM

Powered by Inform